| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/04/2000 | WO2000024744A1 Bicyclic nitrogen heterocycles |
| 05/04/2000 | WO2000024724A1 Thiazole-derivatives |
| 05/04/2000 | WO2000024710A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/04/2000 | WO2000024707A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | WO2000024419A1 Methods for enhancing wound healing |
| 05/04/2000 | WO2000024403A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | WO2000024402A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | WO2000024401A1 Fluticasone lotion having improved vasoconstrictor activity |
| 05/04/2000 | WO2000024398A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | WO2000024393A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | WO2000024378A1 Compositions of microspheres for wound healing |
| 05/04/2000 | WO2000024375A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/04/2000 | WO2000024366A1 Preparations for topical application of substances having antiandrogenic effect |
| 05/04/2000 | WO2000024365A1 Treatment of skin with adenosine or adenosine analog |
| 05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
| 05/04/2000 | WO2000006187A3 Modulation of apoptosis |
| 05/04/2000 | WO2000006085A3 Compounds and methods |
| 05/04/2000 | WO2000004868A3 Libraries of polyhydroxamates and their analogs |
| 05/04/2000 | WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions |
| 05/04/2000 | WO2000002544A3 Use of piperine for treating skin pigmentation disorders |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999062879A8 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 05/04/2000 | WO1999043672A9 Inhibitors of phospholipase a2 |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | CA2349211A1 Prv-1 gene and the use thereof |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2348160A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | CA2347828A1 Methods for enhancing wound healing |
| 05/04/2000 | CA2347365A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 05/04/2000 | CA2347109A1 Fluticasone lotion having improved vasoconstrictor activity |
| 05/04/2000 | CA2342626A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/03/2000 | EP0997457A1 3-benzoylindole derivatives and drugs containing the same |
| 05/03/2000 | EP0997140A1 Skin and/or hair whitening composition |
| 05/03/2000 | EP0996448A1 Treatment and prevention of adhesions |
| 05/03/2000 | EP0996446A1 Novel substituted imidazole compounds |
| 05/03/2000 | EP0996438A1 Use of cis-6-hexadecenoic acid for treating psoriasis, allergies, auto-immune disorders and dry, sensitive skin |
| 05/03/2000 | EP0996434A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 05/03/2000 | EP0996433A1 Methods for treatment of conditions associated with lactosylceramide |
| 05/03/2000 | EP0996428A2 Topical application of a combination of benzoyl peroxide and a second active ingredient |
| 05/03/2000 | EP0996418A1 Dermatological compositions |
| 05/03/2000 | EP0996410A1 Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat seborrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof |
| 05/03/2000 | EP0996409A1 Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor |
| 05/03/2000 | EP0824354A4 Methods to inhibit late radiation-induced skin damage |
| 05/03/2000 | CN1252101A Component of bromelain |
| 05/03/2000 | CN1252099A Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 05/03/2000 | CN1252003A Solvent system for enhanced penetration of pharmaceutical compounds |
| 05/03/2000 | CN1251998A Facililation of wound healing with CM101/GBS toxin |
| 05/03/2000 | CN1251997A Treatment of chronic inflammatory diseases with CM 101/GBS toxin |
| 05/03/2000 | CN1251989A Methods and compositions for preventing and treating chronological aging in human skin |
| 05/03/2000 | CN1251985A Cosmetic and dermatological agent with hard-magnetic particle base |
| 05/03/2000 | CN1251773A Composition having silicone rubber stabilized ascorbic acid components |
| 05/03/2000 | CN1251769A Ointment for treating burn and scald |
| 05/03/2000 | CN1052007C Anti-tanning agent, and light-protection cosmetic composition containing said agent and application thereof |
| 05/03/2000 | CN1052002C 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans, preparation thereof and medicinal composition comprising them |
| 05/03/2000 | CN1051932C Drug for acne and its preparation |
| 05/03/2000 | CN1051928C External-use decoction with Chinese herbal medicines |
| 05/03/2000 | CN1051921C Methods of inhibiting imperfect tissue repair |
| 05/02/2000 | US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/02/2000 | US6057453 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups |
| 05/02/2000 | US6057440 Process for preparing bis-indoly macrocycles |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp |
| 05/02/2000 | US6057351 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetic and pharmaceuticals |
| 05/02/2000 | US6057341 Bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6056955 Topical treatment of streptococcal infections |
| 05/02/2000 | US6056945 Compositions containing silicone-grafted polymer and thickening polymer of (meth)acrylamide derivative |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023451A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023445A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023425A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023417A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023416A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023415A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 04/27/2000 | WO2000023095A2 Method of modulating hair growth |
| 04/27/2000 | WO2000023093A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | WO2000023068A2 Fumaric acid microtablets |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000023043A1 Uv protection compositions |
| 04/27/2000 | WO2000023042A1 Uv protection compositions |
| 04/27/2000 | WO2000023022A1 Method and compositions for in situ formation of protective and/or medicated films on body tissue |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | WO1999062459A9 Agents and methods for protection, treatment and repair of connective tissue |
| 04/27/2000 | WO1999051220A9 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2347204A1 Compositions and methods for promoting tissue repair using heat shock proteins |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |